Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Manufacturers Struggle To Determine Unique Device Identification’s Impact

This article was originally published in The Silver Sheet

Executive Summary

Unique Device Identification (UDI) will touch many parts of a manufacturer’s quality system, including CAPA, complaint handling, design control, design history files and management control, among several other areas. “Your quality system is going to be affected in any area where you deal with a product identifier,” Philips Medical Systems’ Michael Hudon points out. Many firms have already formed UDI implementation teams as they await FDA’s final regulation on the topic.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036650

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel